Skip to main content
. 2021 Apr 9;12:661911. doi: 10.3389/fimmu.2021.661911

Figure 1.

Figure 1

Flow chart of biopsies inclusion and exclusions for the study. We collected 312 kidney biopsy and selected 198 biopsies with an original diagnose of rejection and 114 subjects without rejection. 20 biopsies were redefined as CAAMR and 8 biopsies were defined as CAMR by a central pathologist. In 114 subjects without rejection, 12 patients diagnosed with non-specific lesions or mild drug-induced injuries were defined as Control. We excluded 1 subject with incomplete FFPE slides and 5 subjects with incomplete central pathology data. TCMR, T cell-mediated rejection; ABMR, antibody-mediated rejection; FFPE, formalin-fixed paraffin-embedded.